The increased awareness of antiviral resistance over the past decade h
as paralleled the development of new antiviral agents. While such resi
stant viral isolates are of clinical significance primarily in immunoc
ompromised individuals, the development and transmission of such mutan
ts have been reported in immunocompetent persons as well. As antiviral
agents are increasingly utilised by the clinician, the incidence of s
uch occurrences is likely to increase. Issues relating to mechanisms o
f antiviral resistance, clinical manifestations and significance of re
sistance, and implications for future antiviral development and utilis
ation are reviewed in this article. Viruses that are discussed include
herpes simplex virus, varicella-zoster virus, cytomegalovirus, influe
nza A virus, and human immunodeficiency virus.